Roche, Helsinn Sue Dr. Reddy's Over Bid For Generic Aloxi

Law360, New York (May 14, 2012, 8:44 PM EDT) -- Roche Palo Alto LLC and Helsinn Healthcare SA on Friday hit Dr. Reddy's Laboratories Ltd. with a patent infringement suit challenging the rival drugmaker's attempt to get U.S. approval of a generic version of their anti-nausea medication Aloxi.

In a complaint filed in New Jersey federal court, Roche and Helsinn said that Dr. Reddy's and subsidiary Dr. Reddy's Laboratories Inc., which does business in New Jersey, had infringed its patent by submitting a new drug application to the U.S. Food and Drug Administration.

The application infringes...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.